Skip to main content

Advertisement

Table 2 Response rates of cetuximab in combination with S-1 and oxaliplatin (Ce-SOX) and S-1 and oxaliplatin (SOX) groups

From: Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer

Response Ce-SOX SOX P
Complete response 1 0 -
Partial response 16 11 0.11
Stable disease 10 8 0.18
Progressive disease 4 6 0.15
Response rate (%) 54.8 44.0 0.22
Disease control rate (%) 87.1 76.0 0.16